160 related articles for article (PubMed ID: 25495608)
1. Incidence of lung cancer in patients with systemic sclerosis treated with extracorporeal photopheresis.
Topuzoglu S; Knobler R; Movadat O; Petkov V; Foedinger D; Just U; Pehamberger H; Jantschitsch C
Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):175-83. PubMed ID: 25495608
[TBL] [Abstract][Full Text] [Related]
2. Photopheresis: Advances and Use in Systemic Sclerosis.
Zhou XA; Choi J
Curr Rheumatol Rep; 2017 Jun; 19(6):31. PubMed ID: 28466383
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photopheresis for systemic sclerosis: A meta-analysis of randomized clinical trials.
Delbrück C; Gambichler T; Susok L; Peinemann F
Dermatol Ther; 2022 Jul; 35(7):e15530. PubMed ID: 35445504
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results on long-term follow-up of systemic sclerosis patients under extracorporeal photopheresis.
Gambichler T; Özsoy O; Bui D; Scheel CH; Susok L
J Dermatolog Treat; 2022 Jun; 33(4):1979-1982. PubMed ID: 33944664
[TBL] [Abstract][Full Text] [Related]
5. The assessment of immune-regulatory effects of extracorporeal photopheresis in systemic sclerosis: a long-term follow-up study.
Papp G; Horvath IF; Gyimesi E; Barath S; Vegh J; Szodoray P; Zeher M
Immunol Res; 2016 Apr; 64(2):404-11. PubMed ID: 26168768
[TBL] [Abstract][Full Text] [Related]
6. Use of Extracorporeal Photopheresis in Scleroderma: A Review.
Du AX; Osman M; Gniadecki R
Dermatology; 2020; 236(2):105-110. PubMed ID: 31362294
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan.
Kuo CF; Luo SF; Yu KH; Chou IJ; Tseng WY; Chang HC; Fang YF; Chiou MJ; See LC
Scand J Rheumatol; 2012 Feb; 41(1):44-9. PubMed ID: 22150162
[TBL] [Abstract][Full Text] [Related]
8. Incidence of cancer among patients with systemic sclerosis in Korea: results from a single centre.
Kang KY; Yim HW; Kim IJ; Yoon JU; Ju JH; Kim HY; Park SH
Scand J Rheumatol; 2009; 38(4):299-303. PubMed ID: 19308805
[TBL] [Abstract][Full Text] [Related]
9. Management of severe scleroderma with long-term extracorporeal photopheresis.
Krasagakis K; Dippel E; Ramaker J; Owsianowski M; Orfanos CE
Dermatology; 1998; 196(3):309-15. PubMed ID: 9621138
[TBL] [Abstract][Full Text] [Related]
10. Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies.
Onishi A; Sugiyama D; Kumagai S; Morinobu A
Arthritis Rheum; 2013 Jul; 65(7):1913-21. PubMed ID: 23576072
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis.
Papp G; Horvath IF; Barath S; Gyimesi E; Vegh J; Szodoray P; Zeher M
Clin Immunol; 2012 Feb; 142(2):150-9. PubMed ID: 22036269
[TBL] [Abstract][Full Text] [Related]
12. Malignancies associated with systemic sclerosis.
Szekanecz É; Szamosi S; Horváth Á; Németh Á; Juhász B; Szántó J; Szücs G; Szekanecz Z
Autoimmun Rev; 2012 Oct; 11(12):852-5. PubMed ID: 22410174
[TBL] [Abstract][Full Text] [Related]
13. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides.
Wilson LD; Jones GW; Kim D; Rosenthal D; Christensen IR; Edelson RL; Heald PW; Kacinski BM
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):54-60. PubMed ID: 10863224
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience.
Benden C; Speich R; Hofbauer GF; Irani S; Eich-Wanger C; Russi EW; Weder W; Boehler A
Transplantation; 2008 Dec; 86(11):1625-7. PubMed ID: 19077900
[TBL] [Abstract][Full Text] [Related]
15. Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk.
De Luca G; Bosello SL; Berardi G; Rucco M; Canestrari G; Correra M; Mirone L; Forni F; Di Mario C; Danza FM; Pirronti T; Ferraccioli G
Rheumatology (Oxford); 2015 Nov; 54(11):1991-9. PubMed ID: 26106211
[TBL] [Abstract][Full Text] [Related]
16. The risk of cancer development in systemic sclerosis: a meta-analysis.
Zhang JQ; Wan YN; Peng WJ; Yan JW; Li BZ; Mei B; Chen B; Yao H; Yang GJ; Tao JH; Wang J
Cancer Epidemiol; 2013 Oct; 37(5):523-7. PubMed ID: 23725641
[TBL] [Abstract][Full Text] [Related]
17. Drug monitoring of orally administered 8-methoxypsoralen in patients treated with extracorporeal photopheresis.
Balogh A; Merkel U; Looks A; Vollandt R; Wollina U
Skin Pharmacol Appl Skin Physiol; 1998; 11(4-5):258-65. PubMed ID: 9885410
[TBL] [Abstract][Full Text] [Related]
18. The effects of extracorporeal photochemotherapy on T cell activation and regulatory mechanisms in patients with systemic sclerosis.
Papp G; Barath S; Szegedi A; Szodoray P; Zeher M
Clin Rheumatol; 2012 Sep; 31(9):1293-9. PubMed ID: 22706443
[TBL] [Abstract][Full Text] [Related]
19. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.
Jaksch P; Scheed A; Keplinger M; Ernst MB; Dani T; Just U; Nahavandi H; Klepetko W; Knobler R
J Heart Lung Transplant; 2012 Sep; 31(9):950-7. PubMed ID: 22884382
[TBL] [Abstract][Full Text] [Related]
20. A cohort study of cancer incidence in systemic sclerosis.
Derk CT; Rasheed M; Artlett CM; Jimenez SA
J Rheumatol; 2006 Jun; 33(6):1113-6. PubMed ID: 16622904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]